• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

8.610 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,153
Open 8.610
Bid (Size) 8.410 (100)
Ask (Size) 8.800 (100)
Prev. Close 8.610
Today's Range 8.610 - 8.610
52wk Range 4.720 - 13.74
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeoGenomics Earnings: What To Look For From NEO
April 26, 2026
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results this Tuesday after market close. Here’s what investors should know. ... 
Via StockStory
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
April 24, 2026
What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 4.1% in the afternoon session after the company announced that... 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
-26.8%
-26.8%
1 Month
+19.6%
+19.6%
3 Month
-30.7%
-30.7%
6 Month
-15.3%
-15.3%
1 Year
-13.6%
-13.6%

More News

Read More
News headline image
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
April 23, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
2 Healthcare Stocks Worth Your Attention and 1 We Ignore
April 23, 2026
Via StockStory
NeoGenomics Inc (NASDAQ:NEO) Beats Q4 Earnings Estimates and Provides 2026 Guidance ↗
February 17, 2026
Via Chartmill
News headline image
NeoGenomics (NEO) Q4 2024 Earnings Transcript ↗
April 22, 2026
Via The Motley Fool
Stay updated with the stocks that are on the move in today's after-hours session. ↗
April 22, 2026
Via Chartmill
News headline image
3 Unprofitable Stocks Walking a Fine Line
April 21, 2026
Via StockStory
News headline image
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
April 13, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
April 12, 2026
Via StockStory
News headline image
3 Cash-Burning Stocks We Think Twice About
April 08, 2026
Via StockStory
Topics Economy
News headline image
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
April 07, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
April 02, 2026
Via StockStory
News headline image
2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm
March 23, 2026
Via StockStory
News headline image
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
March 16, 2026
Via StockStory
Topics Economy Stocks
News headline image
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
March 16, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Reasons to Avoid NEO and 1 Stock to Buy Instead
February 25, 2026
Via StockStory
News headline image
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
February 25, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call
February 24, 2026
Via StockStory
Topics Earnings
News headline image
Why NeoGenomics (NEO) Shares Are Falling Today
February 18, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
February 18, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook
February 18, 2026
Via StockStory
News headline image
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Via The Motley Fool
Topics Earnings
News headline image
NeoGenomics’s (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates
February 17, 2026
Via StockStory
Topics Earnings
News headline image
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
February 17, 2026
From NeoGenomics, Inc.
Via Business Wire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 8.610
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 04/27/26 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.06B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap